TP53 and glioblastoma: The anti-proliferative activity of 136 was evaluated against GBM cells and human T98G cells (exhibitingmutated p53), where it inhibited GBM cell growth with IC50 = 116 ± 10 nM, while efficacy against T98G cells was observedat micromolar concentrations.